Financial Engines Advisors L.L.C. Purchases 1,428 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Financial Engines Advisors L.L.C. lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 59.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,835 shares of the healthcare conglomerate’s stock after buying an additional 1,428 shares during the period. Financial Engines Advisors L.L.C.’s holdings in UnitedHealth Group were worth $1,940,000 as of its most recent filing with the SEC.

Other large investors have also bought and sold shares of the company. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at approximately $25,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at $30,000. Promus Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter worth $32,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group during the third quarter valued at about $37,000. Finally, Pillar Financial Advisors LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $40,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE UNH opened at $518.10 on Thursday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a market cap of $473.92 billion, a P/E ratio of 33.43, a PEG ratio of 1.37 and a beta of 0.62. The company has a fifty day simple moving average of $508.60 and a 200 day simple moving average of $545.37. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the firm earned $5.83 EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is 54.19%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. Truist Financial reduced their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Barclays decreased their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Finally, Oppenheimer upped their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $629.32.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.33% of the stock is owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.